SCHEMBL30304501

SCHEMBL30304501

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCCCCCCCCCCN)cc21

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 20/20 0.68
DDB1 Q16531 19/20 0.68
IKZF3 Q9UKT9 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30392916 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL30392434 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL30391734 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL25123851 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL25123420 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL23832528 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL23842262 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL25123805 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL22776655 1.00 CRBN (0.68) CRBNDDB1IKZF3
SCHEMBL26634963 1.00 CRBN (0.68) CRBNDDB1IKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055952-A1 NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) DEGRADING COMPOUNDS C4 THERAPEUTICS, INC. (US) 2023-04-06 WO disclosed